MedPath

Tapentadol nasal spray- a better alternative than intavenous tramadol and diclofenac

Not Applicable
Conditions
Health Condition 1: G891- Acute pain, not elsewhere classified
Registration Number
CTRI/2021/09/036432
Lead Sponsor
Rajendra Institute of Medical Sciences Ranchi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

UNDERGOING ANY TYPE OF SURGICAL PROCEDURE

Exclusion Criteria

PATIENTS OPTING OUT OF STUDY OR HAVING SEVERE CARDIOVASCULAR OR RENAL RISK FACTORS

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
REDUCTION IN POST-SURGICAL PAINTimepoint: REDUCTION IN POST-SURGICAL PAIN measured on day 1, 2 and 3 and overall satisfaction measured on goal attainment scale
Secondary Outcome Measures
NameTimeMethod
overall satisfaction measured on goal attainment scaleTimepoint: at the time of discharge
© Copyright 2025. All Rights Reserved by MedPath